DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2016.
In the first quarter net revenue grew 3.2% year on year to $400.5 million from $388.2 million in the same quarter last year. This represented 4.9% constant currency growth and 1.2% constant dollar organic growth year on year.
